http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107474128-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43504 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-108 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 |
| filingDate | 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107474128-B |
| titleOfInvention | A kind of bionical hemostasis biogum |
| abstract | The present invention provides a kind of bionical hemostasis biogum, and amino acid sequence is SEQ ID NO:1: the present invention also provides a kind of hemostatic material, the hemostatic material includes the sodium alginate of the albumen that amino acid sequence is SEQ ID NO:1 and Dopa modification.The present invention, which provides one kind, has anthemorrhagic performance product, is prepared into using the polypeptide and sodium alginate derivative for the preparation that amino acid sequence is SEQ ID NO:1ï¼›Using the result shows that amino acid sequence is that the addition of the albumen of SEQ ID NO:1 improves the ultra microstructure of material, experiment in vitro proves that composite material has good haemostatic effect. |
| priorityDate | 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.